España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AB Corporate Bond ETF
EYEG
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$35.48
0.11
0.31%
At close: -
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for AB Corporate Bond ETF (NASDAQ:EYEG)
AB Corporate Bond ETF (NASDAQ: EYEG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, October 01, 2021
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, September 30, 2021
Eyegate Pharmaceuticals Files For Patent Application Titled 'COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE BY CONTACT LENS MEDIATED DRUG DELIVERY'
Michael Horton
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
EYEG: Refreshed and moving forward
Zacks Small Cap Research
Eyegate Pharmaceuticals Shares See Volume, He...
Michael Horton
Thursday, September 23, 2021
EyeGate Pharma US Patent & Trademark Office A...
Benzinga Newsdesk
Wednesday, September 15, 2021
46 Biggest Movers From Yesterday
Lisa Levin
Tuesday, September 14, 2021
36 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
20 Stocks Moving in Tuesday's Pre-Market Session
Lisa Levin
Wednesday, September 08, 2021
EyeGate Pharma Completes Target Enrollment In...
Benzinga Newsdesk
Thursday, August 19, 2021
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Shanthi Rexaline
Wednesday, August 18, 2021
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, August 17, 2021
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Shanthi Rexaline
Monday, August 16, 2021
HC Wainwright & Co. Maintains Buy on Eyegate ...
Benzinga Newsdesk
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, August 13, 2021
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Shanthi Rexaline
Thursday, August 12, 2021
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Shanthi Rexaline
Wednesday, August 11, 2021
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Shanthi Rexaline
85 Biggest Movers From Yesterday
Lisa Levin
Tuesday, August 10, 2021
Mid-Afternoon Market Update: 3D Systems Surges On Upbeat Earnings; Katapult Shares Drop
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Mid-Day Market Update: Crude Oil Rises Over 3%; comScore Shares Plummet
Lisa Levin
54 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
Shanthi Rexaline
Eyegate Pharmaceuticals shares are trading lo...
Benzinga Newsdesk
EyeGate Announces $10.75M Registered Direct O...
Benzinga Newsdesk
Monday, August 09, 2021
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, August 06, 2021
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Shanthi Rexaline
Thursday, August 05, 2021
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Shanthi Rexaline
Tuesday, August 03, 2021
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Shanthi Rexaline
Monday, August 02, 2021
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
63 Biggest Movers From Yesterday
Lisa Levin
Friday, July 30, 2021
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Shanthi Rexaline
Thursday, July 29, 2021
62 Biggest Movers From Yesterday
Lisa Levin
Wednesday, July 28, 2021
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
50 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
62 Biggest Movers From Yesterday
Lisa Levin
Tuesday, July 27, 2021
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
44 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Eyegate Pharmaceuticals Shares Are Skyrocketing Today
Henry Khederian
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Shanthi Rexaline
Show More